T-cell-mediated and humoral approaches to universal influenza vaccines

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

Maja A Sommerfelt is an employee of Bionor Pharma ASA and owns shares in the company. The influenza project has been supported in part by a grant from the Research Council of Norway FUGE Programme. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.